Tus-Pharmaceutical Group Co., Ltd. (SHE:000590)
China · Delayed Price · Currency is CNY 12.04
+0.04 (0.33%)
Sep 11, 2025, 2:45 PM CST
Tus-Pharmaceutical Group Revenue
Tus-Pharmaceutical Group had revenue of 77.22M CNY in the quarter ending June 30, 2025, with 11.01% growth. This brings the company's revenue in the last twelve months to 338.99M, down -6.16% year-over-year. In the year 2024, Tus-Pharmaceutical Group had annual revenue of 343.21M, down -15.18%.
Revenue (ttm)
338.99M
Revenue Growth
-6.16%
P/S Ratio
8.50
Revenue / Employee
292.49K
Employees
1,159
Market Cap
2.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 343.21M | -61.44M | -15.18% |
| Dec 31, 2023 | 404.65M | 54.12M | 15.44% |
| Jan 1, 2023 | 350.53M | 49.75M | 16.54% |
| Jan 1, 2022 | 300.77M | 25.68M | 9.34% |
| Dec 31, 2020 | 275.09M | -39.94M | -12.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |